ORAMED PHARMACEUTICALS INC. — Form D
ORAMED PHARMACEUTICALS INC. of JERUSALEM, L3, a company, filed a Form D exempt-offering notice with the SEC on 2014-11-14. The offering totals $5.0M. Industry: Pharmaceuticals.
Offering
- Filed: 2014-11-14
- Form: D
- Accession: 0001178913-14-003565
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.0M
- Remaining: $5.0M
- Minimum investment: $5.0M
- Investors: 1
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-228414
Issuer
- Name: ORAMED PHARMACEUTICALS INC.
- CIK: 0001176309
- Entity type: Corporation
- Jurisdiction: NEVADA
- Address: HI-TECH PARK 2/5 GIVAT-RAM, JERUSALEM, L3, 91390
- Phone: +972-2-566-0001
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Michael Berelowitz | Director | NEW YORK, NY |
| Harold Jacob | Director | JERUSALEM, L3 |
| Miriam Kidron | Director | JERUSALEM, L3 |
| Nadav Kidron | Director | JERUSALEM, L3 |
| Gerald M Ostrov | Director | Long Branch, NJ |
| Leonard Sank | Director | CAPE TOWN, T3 |
| Joshua Hen Hexter | Executive Officer | Jerusalem, L3 |
| Miriam Kidron | Executive Officer | JERUSALEM, L3 |
| Nadav Kidron | Executive Officer | JERUSALEM, L3 |
| Yifat Hen Zommer | Executive Officer | Jerusalem, L3 |
| Gerald Martin Ostrov | Director | LONG BRANCH, NJ |
| Yifat Martin Zommer | Executive Officer | REHOVOT, L3 |
| Yifat Zommer | Executive Officer | REHOVOT, L3 |
Other filings by this issuer (8)
More